(Q53407433)

14 May 2018

title

Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study. (English)

1 reference

14 May 2018

1 reference

4

Jenette Creaney

1 reference

14 May 2018

author name string

Eun-Kee Park

1

1 reference

14 May 2018

Alessandra Sandrini

2

1 reference

14 May 2018

Deborah H Yates

3

1 reference

14 May 2018

Bruce W Robinson

5

1 reference

14 May 2018

Paul S Thomas

6

1 reference

14 May 2018

Anthony R Johnson

7

1 reference

14 May 2018

language of work or name

English

0 references

publication date

26 June 2008

1 reference

14 May 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

14 May 2018

volume

178

1 reference

14 May 2018

issue

8

1 reference

14 May 2018

page(s)

832-837

1 reference

14 May 2018

Mineral fibre analysis and routes of exposure to asbestos in the development of mesothelioma in an English region

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Role of asbestos in etiology of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

A review of chemotherapy trials for malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Integration of multimodality approaches in the management of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Projected mesothelioma incidence in men in New South Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

MESOMARK: a potential test for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Application of Mesothelin Immunostaining in Tumor Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Diagnosis and initial management of nonmalignant diseases related to asbestos

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Asbestos-related benign pleural disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Asbestos, asbestosis, and lung cancer: a critical assessment of the epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Mesothelin-family proteins and diagnosis of mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Combined CA125 and Mesothelin Levels for the Diagnosis of Malignant Mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Reattendance at hospital for asthma in two Australian states, 2000?2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Soluble Mesothelin–related Peptides in the Diagnosis of Malignant Pleural Mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

Utility of Osteopontin and Serum Mesothelin in Malignant Pleural Mesothelioma Diagnosis and Prognosis Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200802-258OC

10.1164/RCCM.200802-258OC

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

18583574

1 reference

14 May 2018